LLS News Network

(Rye Brook, NY, June 12, 2018) – Despite the many advances in cancer treatments and survival rates, many patients still are living with cancer and experiencing the darkness that can come with it. That’s why The Leukemia & Lymphoma Society (LLS) conceived Random Acts of Light Day, in conjunction with its flagship fundraising campaign – Light The Night (LTN) (www.LightTheNight.org) – a series of 140 inspiri...

Rye Brook, NY – June 11, 2018 – The U.S. Food and Drug Administration (FDA) decision to expand the approval of a targeted therapy for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) is a significant development in the treatment of these patients, according to The Leukemia & Lymphoma Society® (LLS). The FDA approved venetoclax (Venclexta®...

  (Rye Brook, NY, June 7, 2018) – For the second year in a row, high school students across the country are redefining what it means to be philanthropic in today’s youth culture. Through The Leukemia & Lymphoma Society’s (LLS) newest innovation in fundraising, Students of the Year, more than 600 motivated high school students raised significant funds for LLS’s cutting-edge cancer research and ...

Camden, NJ (June 1, 2018) – Everyone loves a three-peat, especially when the winning combination helps provide care and support to people fighting cancer. For the third consecutive year, Subaru of America, Inc. and The Leukemia & Lymphoma Society (LLS) will spread love, hope and warmth to cancer patients and their families in communities across the country. Over the past two years, Subaru Loves to Care, the...

View multimedia release here. Rye Brook, N.Y. (May 7, 2018) – The Leukemia & Lymphoma Society (LLS), the largest nonprofit dedicated to fighting blood cancers, today unveiled a new brand platform showcasing its work in the fight to cure cancers. “Beating Cancer Is In Our Blood” highlights LLS’s resolve to end blood cancers, the third leading cause of cancer deaths in the U.S., and sh...